Pharmaceutical company developing controlled-release intraocular implants for ophthalmology.
| Date | Round | Amount |
|---|---|---|
| Dec 2021 | Funding round Belgian ophthalmology drug developer EyeD Pharma raised EUR 45M from Belgian families, life-science entrepreneurs and public funds to advance its first human clinical study. | $53.1M |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.